We found in nuclear run-on transcription assays that a functional Brm gene was present and actively transcribed in all of the Brm-deficient cancer cell lines tested12, 16, indicating that Brm expression is largely suppressed by post-transcriptional gene silencing. The gene discussed is SMARCA2; the disease is cancer.